The expression of the BCL-2 gene was also lower in the MetS group compared to the healthy group at the same PPE dose of 100 mg/kg (Figure 7), and a similar tendency was observed in BAX expression (p = 0.0525, Figure 6). This evidence concerns the gene BCL2 and metabolic syndrome.